NORDIC BIOTECH ADVISORS ApS
CVR 26123925 · Private limited company (ApS) · Active · Low risk
NORDIC BIOTECH ADVISORS ApS is a Private limited company (ApS), founded on , based in Hellerup. The company is registered in the industry andre aktiviteter i forbindelse med finansielle tjenesteydelser, undtagen forsikring og pensionsforsikring. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 4.6m and a net result of DKK 360k.
Bankruptcy risk for NORDIC BIOTECH ADVISORS ApS
0.0 × the average (1.41%) · higher risk than 15% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 26123925
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (25 years)
- Address
- c/o NB Capital ApS, Strandvejen 125
2900 Hellerup - Municipality
- København
- Industry
- Andre aktiviteter i forbindelse med finansielle tjenesteydelser, undtagen forsikring og pensionsforsikring (661900)
Bankruptcies in the industry: Formueforvaltning - Share capital
- DKK 125k
- Employees
- 3 (2018)
- Auditor
- DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 25 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 85.9% |
| Current ratio | 689% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 4 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 114 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK 3.3m | DKK 1.9m | DKK 4.4m |
| Net profit | DKK 360k | DKK -573k | DKK 1.4m |
| Equity | DKK 4.6m | DKK 4.3m | DKK 4.8m |
| Total assets | DKK 5.4m | DKK 5.3m | DKK 5.3m |
| Cash | DKK 1.1m | DKK 3.5m | – |
| Short-term debt | DKK 760k | DKK 1.1m | – |
| Tax owed | DKK 327k | DKK 16k | – |
| Avg. employees | 2 | 2 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Deloitte Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 181 | ||
| 1 Jan 2024 – 31 Dec 2024 | 179 | ||
| 1 Jan 2023 – 31 Dec 2023 | 171 | ||
| 1 Jan 2022 – 31 Dec 2022 | 181 | ||
| 1 Jan 2021 – 31 Dec 2021 | 182 | ||
| 1 Jan 2020 – 31 Dec 2020 | 162 | Restated | |
| 1 Jan 2019 – 31 Dec 2019 | 163 | ||
| 1 Jan 2018 – 31 Dec 2018 | 151 | ||
| 1 Jan 2017 – 31 Dec 2017 | 152 | ||
| 1 Jan 2016 – 31 Dec 2016 | 169 | ||
| 1 Jan 2015 – 31 Dec 2015 | 162 | ||
| 1 Jan 2014 – 31 Dec 2014 | 151 | ||
| 1 Jan 2013 – 31 Dec 2013 | 175 | ||
| 1 Jan 2012 – 31 Dec 2012 | 156 | ||
| 1 Jan 2011 – 31 Dec 2011 | 161 | ||
| 1 Jan 2010 – 31 Dec 2010 | 41 | ||
| 1 Jan 2009 – 31 Dec 2009 | 35 | ||
| 1 Jan 2008 – 31 Dec 2008 | 35 | ||
| 1 Jan 2007 – 31 Dec 2007 | 38 | ||
| 1 Jan 2006 – 31 Dec 2006 | 81 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Christian Karsten Hansen | ||
| CEO | Cora Louise Madsen | ||
| CEO | Jennifer Louise Prender | ||
| Board | Florian Schønharting | Current | |
| Board | Jakob Mosegaard Larsen | Current | |
| Board | Christian Karsten Hansen | ||
| Board | Lars Henrik Munch | ||
| Board | Erik Hoffmeyer | ||
| Board | Matthew Daniel Perry | ||
| Owner (25%) | C. HANSEN INVEST ApS | Current | |
| Owner (33%) | TECH GROWTH INVEST ApS | Current | |
| Owner (25%) | BVF/Nexgen Biotech, LP | Current | |
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Auditor | Benny Lynge Sørensen | ||
| Auditor | ERNST & YOUNG DENMARK P/S | ||
| Auditor | ERNST & YOUNG DENMARK P/S | ||
| Founder | TECH GROWTH INVEST ApS | Current | |
| Founder | CKH INVEST ApS | Current |
The CEOs' other companies
Christian Karsten Hansen – 23 other companies, of which 1 bankrupt
- H PHARMACEUTICALS GENERAL PARTNER ApS Bankrupt 7 Aug 2012
- C. HANSEN INVEST ApS Active
- CKH INVEST ApS Opløst
- CURALOGIC A/S Opløst
- ENTROP PHARMA ApS Opløst
- FORWARD PHARMA A/S Opløst
- HYSCITE DISCOVERY A/S Compulsorily dissolved
- MAXYGEN ApS Opløst
- NB PUBLIC EQUITY INVEST ApS Active
- NORDIC BIOTECH GENERAL PARTNER ApS Opløst
- NORDIC BIOTECH GENERAL PARTNER II ApS Opløst
- NORDIC BIOTECH INCENTIVE ApS Opløst
- NORDIC BIOTECH INCENTIVE II ApS Opløst
- NUEVOLUTION A/S Active
- OSTEOLOGIX ApS Opløst
- POALIS A/S Opløst
- PROFOUND INVEST A/S Opløst
- ParaTech ApS Active
- RODDAX ApS Opløst
- ROSE PHARMA A/S Compulsorily dissolved
- SPREE PHARMA A/S Opløst
- SUNIN GENERAL PARTNER ApS Opløst
- TECH GROWTH INVEST ApS Active
Cora Louise Madsen – 6 other companies
- CHASE INVEST A/S Opløst
- ENTROP PHARMA ApS Opløst
- NB PUBLIC EQUITY INVEST ApS Active
- NB PUBLIC EQUITY KOMPLEMENTAR ApS Active
- ROSE PHARMA A/S Compulsorily dissolved
- SCHRODER ADMINISTRATION A/S Opløst
Address history (3 moves)
| c/o NB Capital ApS, Strandvejen 125, 2900 Hellerup | |
| c/o NB Capital ApS, Østergade 24A, 1. tv, 1100 København K | |
| Østergade 5, 3., 1100 København K | |
| c/o LINDH STABELL HORTEN A/S, Ved Stranden 18, 1012 København K |
Former names
| NORDIC BIOTECH ADVISORS ApS | – now |
| NEXGEN BIOTECH ApS | – |
| NORDIC BIOTECH ApS | – |
Employees per year
Other companies at the same address
- E & S - Consult IVS Bankrupt
- Redline Media Group ApS Bankrupt
- VIA Telegroup Danmark ApS Bankrupt
- AL Copenhagen A/S Active
- AP Management ApS Active
- AarhusGeoSoftware ApS Opløst
- Administrationsselskabet i "Buen" ApS Active
- Andersen & Friends Holding ApS Active
- BAKKEDAL INVEST ApS Opløst
- BESTYRELSESPOSTEN ApS Opløst
- BIOGEN (DENMARK) A/S Active
- Biofuel Technology Holding ApS Active
- Borderless Denmark Holdings ApS Active
- CAPNORDIC HOLDING ApS Active
- CKIT HOLDING ApS Active
- CKIT Software ApS Opløst
- COHAMI HOLDING ApS Opløst
- CREDITSAFE DENMARK ApS Active
- Clarify Commerce ApS Active
- Classic Maritime ApS Active
- CoreWeave SVL01 ApS Active
- Crone Burmeister Adv. ApS Active
- CyberOne ApS Active
- Dansk Demetra ApS Active
- Davy DebtCo ApS Active
Similar companies in København
- GLOBAL BLUE DANMARK A/S København K
- Komplementar 9. oktober 2026 ApS København K
- Paer Financial Services A/S København K
- BRIEFLIE PAYMENTS ApS København K
- UG Drift ApS København K
- TORTUE Formue ApS København K
- Færk Family Office ApS København S
- Vizier Capital Advisors ApS Hellerup
- GavekortRetur ApS København N
- Almenr Fælleskredit ApS København NV
- BAS Brokers ApS København K
- AshGrove Capital Nordics ApS København K
Questions and answers about NORDIC BIOTECH ADVISORS ApS
Has NORDIC BIOTECH ADVISORS ApS gone bankrupt?
No, NORDIC BIOTECH ADVISORS ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of NORDIC BIOTECH ADVISORS ApS?
Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the auditor of NORDIC BIOTECH ADVISORS ApS?
NORDIC BIOTECH ADVISORS ApS most recently used DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was NORDIC BIOTECH ADVISORS ApS founded?
NORDIC BIOTECH ADVISORS ApS was founded on 29 June 2001.
What is the equity of NORDIC BIOTECH ADVISORS ApS?
Equity was DKK 4.6m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.